Licensing agreement reached

Derma Sciences, Inc. (Princeton, NJ) has obtained a licensing agreement with C-Boot LTD, a medical biosystems company based in Israel.
The agreement was established for the marketing, sales, and distribution rights of C-Boot’s patented advanced therapeutic devices for the treatment of chronic venous insufficiency, venous ulcers, and lymphedema; deep vein thrombosis prevention; and other conditions that require compression therapy.
Derma Sciences will market C-Boot’s products under the MOBILITY 1™ brand. The products are the world’s first and only intermittent pneumatic compression (IPC) therapy devices for all these indications, allowing full patient mobility. Several US patents cover the technologies inherent within the device.
Until now, IPC therapy has required that the patient remain immobile while connected to a large pneumatic compressor. Ambulatory treatments have been limited to compression wraps and stockings that have decreased patient compliance, are painful, and do not provide optimal therapy.
This system can be activated either by kinetic energy created from the patient walking (fully utilizing the patient’s calf muscle pump) or by a small, portable compressor.
Patients now will be able to maintain their regular lifestyle by taking therapy wherever they go. The products are easy to wear and use.
For more information, visit www.dermasciences.com or call (609) 514-4744.